Skip to Main Content

Paper Details

A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma.
Pediatr Blood Cancer
17
2021
4E-BP1, Everolimus, LGG, Patients, c-Myc, everolimus, low-grade glioma, mucositis, neurofibromatosis type 1, neutropenia, patient, patients, pediatric, phospho-S6
Author NameAffiliation
Stephen P HungerChildren's Hospital Colorado
Stephen P HungerChildren's Hospital Colorado
Kenneth J CohenThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jeffrey C AllenNew York University Medical Center
Amy SmithUniversity of Florida Health Shands Cancer Hospital
Amy SmithUniversity of Florida Health Shands Cancer Hospital
Kellie J NazemiOHSU Doernbecher Children's Hospital
Matthias A KarajannisMemorial Sloan Kettering Cancer Center
Alexander A VinksCincinnati Children's Hospital Medical Center
Sanjay P PrabhuBoston Children's Hospital
Mark W Kieran
Mark W Kieran
  • 1 - 12

Datasets

Release 1.2